1,3-Bis((S)-1-(naphthalen-1-yl)ethyl)-1H-imidazol-3-ium chloride, 97%, 100mg

1-((5-Bromothiophen-2-yl)sulfonyl)-1H-pyrazole, 98.0%, 100mg

3-PYRIDINEACETONITRILE, 6-(TRIFLUOROMETHYL)-, 95.0%, 5g

METHYL 4-(TERT-BUTOXYCARBONYLAMINO)-1-METHYLPIPERIDINE-4-CARBOXYLATE, 95.0%, 1g

3-((Benzyloxy)methyl)cyclobutanone, 95.0%, 25g

METHYL 2-(4-(4-CYCLOPROPYLNAPHTHALEN-1-YL)-4H-1,2,4-TRIAZOL-3-YLTHIO)ACETATE, 97.0%, 5g

Dicyclohexyl(2,4,6-triisopropylphenyl)phosphine, 98%, 5g

tert-Butyl (2-(1H-indol-3-yl)ethyl)carbamate, 95.0%, 5g

(S)-5-BROMO-2,3-DIHYDRO-1H-INDEN-1-OL, 95.0%, 250mg

2-(4-Bromophenyl)-1,1,1,3,3,3-hexafluoropropan-2-ol, 98%, 100mg

Long working distance plan phase Fluarex contrast 20x/0.45 infinity corrected IOS objective, corrected for 1 mm petri dish thickness

4-Isopropylfuran-2-carbaldehyde, 97%, 100mg

2-Bromo-1-iodo-3-methoxybenzene, 95.0%, 250mg